Grayling, M <br/><br/>
Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis.  [electronic resource] 

 -  The Journal of thoracic and cardiovascular surgery  Feb 2003 
 - 426-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0022-5223 
<br/><br/><label>Standard No.: </label>10.1067/mtc.2003.140  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aortic Valve Insufficiency--etiology<br/>Blood Gas Analysis<br/>Cardiopulmonary Bypass--adverse effects<br/>Cardiotonic Agents--therapeutic use<br/>Dopamine--therapeutic use<br/>Echocardiography, Transesophageal<br/>Endocarditis, Bacterial--complications<br/>Guanylate Cyclase--antagonists & inhibitors<br/>Humans<br/>Hypotension--drug therapy<br/>Inflammation<br/>Male<br/>Methylene Blue--pharmacology<br/>Mitral Valve Insufficiency--etiology<br/>Nitric Oxide--physiology